This inaugural translation symposium will highlight the Crick’s cutting-edge translational programmes and initiatives.
The Inaugural Crick Translational Research Symposium will showcase the Crick’s cutting-edge translational programmes and aims to provide opportunities for accelerating and maximizing future impact. This forum will connect Crick scientists with industry and investor professionals to explore the translational research landscape and foster cross-sector collaboration and investment.
This event is part of London Science Week.
Public registration will open later this year. If you would like to be added to the waiting list, please email translation@crick.ac.uk.
Dave Allen
The Francis Crick Institute, Director of Translation
Katie Bentley
The Francis Crick Institute, Group Leader
Maina Bhaman
Sofinnova Capital Strategy, Partner
Kate Bingham (Keynote)
SV Health Investors, Managing Partner
Paola Bonfanti
The Francis Crick Institute, Principal Group Leader
Simon Boulton
The Francis Crick Institute, Principal Group Leader - Assistant Research Director
Jacob Bush
GSK, Director of Chemical Biology
Lucy Collinson
The Francis Crick Institute, Head of Electron Microscopy
Lindsay Edwards
Relation Therapeutics, Chief Technology Officer and Head of Platform
Radoslav Enchev
The Francis Crick Institute, Senior Group Leader
Pietro Fratta
The Francis Crick Institute, Group Leader (Satellite)
Edith Heard
The Francis Crick Institute, Chief Executive Officer
Tony Hickson
Cancer Research Horizon, Chief Business Officer
Martin Main
Catapult Medicines Discovery, Chief Scientific Officer
Neil McDonald
The Francis Crick Institute, Principal Group Leader
Jens Nielsen
BioInnovation Institute, Chief Executive Officer
James O’Shaughnessy
Newmarket Strategy, Senior Partner
Kevin Pojasek
Enara Bio, President and Chief Executive Officer
Edward McGowan
The Francis Crick Institute
Jonathan Hare
The Francis Crick Institute
.svg)
